经皮胆道金属支架植入治疗恶性梗阻性黄疸术后支架再狭窄的研究进展 -《介入放射学杂志》

参考文献/References:

［1］ Brown KT， Covey AM. Management of malignant biliary obstruction［J］. Tech Vasc Interv Radiol， 2008， 11： 43- 50.
［2］ Saluja SS， Gulati M， Garg PK， et al. Endoscopic or percutaneous biliary drainage for gallbladder cancer： a randomized trial and quality of life assessment［J］. Clin Gastroenterol Hepatol， 2008， 6： 944- 950.
［3］ Kloek JJ， van der Gaag NA， Aziz Y， et al. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma［J］. J Gastrointest Surg， 2010， 14： 119- 125.
［4］ Lee SH， Park JK， Yoon WJ， et al. Optimal biliary drainage for inoperable Klatskin’s tumor based on Bismuth type［J］. World J Gastroenterol， 2007， 13： 3948- 3955.
［5］ Ho CS， Warkentin AE. Evidence- based decompression in malignant biliary obstruction［J］. Korean J Radiol， 2012， 13（Suppl 1）： S56- S61.
［6］ Paik WH， Park YS， Hwang JH， et al. Palliative treatment with self- expandable metallic stents in patients with advanced type Ⅲor Ⅳ hilar cholangiocarcinoma： a percutaneous versus endoscopic approach［J］. Gastrointest Endosc， 2009， 69： 55- 62.
［7］ Jo JH， Park BH. Suprapapillary versus transpapillary stent placement for malignant biliary obstruction： which is better?［J］. J Vasc Interv Radiol， 2015， 26： 573- 582.
［8］ Huang X， Shen L， Jin Y， et al. Comparison of uncovered stent placement across versus above the main duodenal papilla for malignant biliary obstruction［J］. J Vasc Interv Radiol， 2015， 26： 432- 437.
［9］ Lee SJ， Kim MD， Lee MS， et al. Comparison of the efficacy of covered versus uncovered metallic stents in treating inoperable malignant common bile duct obstruction： a randomized trial［J］. J Vasc Interv Radiol， 2014， 25： 1912- 1920.
［10］ Rivera- Sanfeliz GM， Assar OS， Laberge JM， et al. Incidence of important hemobilia following transhepatic biliary drainage： left- sided versus right- sided approaches［J］. Cardiovasc Intervent Radiol， 2004， 27： 137- 139.
［11］钱晓军，戴定可，翟仁友，等．经皮肝穿胆汁引流术后胆道出血的临床分析［J］．介入放射学杂志， 2007， 16： 702- 704．
［12］ Scheer F， Wissgott C， Ludtke CW， et al. Single- phase percutaneous recanalization of malignant bile duct obstructions with a covered stent graft［J］. Rofo， 2014， 186： 394- 399.
［13］ Guaglianone E， Cardines R， Vuotto C， et al. Microbial biofilms associated with biliary stent clogging［J］. FEMS Immunol Med Microbiol， 2010， 59： 410- 420.
［14］ Bezzi M， Zolovkins A， Cantisani V， et al. New ePTFE/FEP- covered stent in the palliative treatment of malignant biliary obstruction［J］. J Vasc Interv Radiol， 2002， 13： 581- 589.
［15］ Silvis SE， Sievert CE， Vennes JA， et al. Comparison of covered versus uncovered wire mesh stents in the canine biliary tract［J］. Gastrointest Endosc， 1994， 40： 17- 21.
［16］ Hausegger KA， Kleinert R， Lammer J， et al. Malignant biliary obstruction： histologic findings after treatment with self- expandable stents［J］. Radiology， 1992， 185： 461- 464.
［17］ Kitano M， Yamashita Y， Tanaka K， et al. Covered self- expandable metal stents with an anti- migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma： a randomized multicenter trial［J］. Am J Gastroenterol， 2013， 108： 1713- 1722.
［18］ Sung J. Are covered stents superior to uncovered stents in the management of malignant biliary obstruction?［J］. Nat Clin Pract Gastroenterol Hepatol， 2004， 1： 20- 21.
［19］ Krokidis M， Fanelli F， Orgera G， et al. Percutaneous palliation of pancreatic head cancer： randomized comparison of ePTFE/FEP- covered versus uncovered nitinol biliary stents［J］. Cardiovasc Intervent Radiol， 2011， 34： 352- 361.
［20］杨杰，令狐恩强，王银川．胆管纳米银涂层抗菌塑料支架的研制［J］．中国医疗器械杂志， 2011， 35： 352- 355．
［21］ Shinchi H， Takao S， Nishida H， et al. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma［J］. J Surg Oncol， 2000， 75： 89- 94.
［22］ Isayama H， Tsujino T， Nakai Y， et al. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma［J］. World J Gastroenterol， 2012， 18： 2364- 2370
［23］ Won JH， Lee JD， Wang HJ， et al. Effects of a holmium- 166 incorporated covered stent placement in normal canine common bile ducts［J］. J Vasc Interv Radiol， 2005， 16： 705- 711.
［24］ He GJ， Yu FQ， Wu R， et al. 103Pd- induced apoptosis of proliferative smooth muscle cells in bile ducts of dogs： significance and effects on related genes［J］. Hepatobiliary Pancreat Dis Int， 2007， 6： 521- 526.
［25］李文会，罗剑钧，戴真煜，等．腔内近距离放疗联合及支架植入治疗恶性胆道梗阻［J］．介入放射学杂志， 2015， 24： 215- 218．
［26］ Chen Y， Wang XL， Yan ZP， et al. The use of 125I seed strands for intraluminal brachytherapy of malignant obstructive jaundice［J］. Cancer Biother Radiopharm， 2012， 27： 317- 323.
［27］ Zhu HD， Guo JH， Zhu GY， et al. A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction： preliminary results versus a conventional biliary stent［J］. J Hepatol， 2012， 56： 1104- 1111.
［28］ Khorsandi SE， Zacharoulis D， Vavra P， et al. The modern use of radiofrequency energy in surgery， endoscopy and interventional radiology［J］. Eur Surg， 2008， 40： 204- 210.
［29］ Li TF， Huang GH， Li Z， et al. Percutaneous transhepatic cholangiography and intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction［J］. J Vasc Interv Radiol， 2015， 26： 715- 721.
［30］崔宁，李晓群．经皮经肝双极射频消融导管恶性梗阻性黄疸20例［J］．介入放射学杂志， 2014， 23： 693- 697．
［31］ Pai M， Valek V， Tomas A， et al. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction： feasibility and early results［J］. Cardiovasc Intervent Radiol， 2014， 37： 235- 240.
［32］夏宁，程永德，王忠敏．胆道支架再狭窄的介入治疗进展［J］．介入放射学杂志， 2014， 23： 82- 85．
［33］任建庄，张凯，李腾飞，等．中下段胆总管癌致恶性梗阻性黄疸介入治疗疗效分析［J］．介入放射学杂志， 2015， 24： 409- 413．

相似文献/References:

[1]梁松年,苏洪英,冯博,等.恶性梗阻性黄疸介入治疗后近期并发症的分析和处理[J].介入放射学杂志,2012,(11):927.
　LIANG Song? nian,SU Hong? ying,FENG Bo,et al. The postoperative short- term complications of interventional therapy for malignant obstructive jaundice： its analysis and management[J].journal interventional radiology,2012,(01):927.
[2]娄继滨,区家乐,胡红耀,等. DSA导引下经皮肝穿胆道引流术穿刺道安全的探讨[J].介入放射学杂志,2012,(10):860.
　LOU Ji- bin,OU Jia- le,HU Hong- yao,et al. DSA- guided percutaneous transhepatic biliary drainage： an investigation of the safety of the puncturing tract[J].journal interventional radiology,2012,(01):860.
[3]郑琳,郭晨阳,黎海亮,等.C臂CT在经皮经肝胆道引流术治疗梗阻性黄疸中的应用[J].介入放射学杂志,2013,(12):1007.
　ZHENG Lin,GUO Chen? yang,LI Hai? liang,et al. The application of C?蛳 arm CT in performing PTCD for obstructive jaundice[J].journal interventional radiology,2013,(01):1007.
[4]莫伟,徐源,阳秀春,等.PTBD患者院外带管生活体验的质性研究 [J].介入放射学杂志,2018,27(02):178.
　MO Wei,XU Yuan,YANG Xiuchun,et al.The quality of life of post- discharge patients carrying drainage tube after PTBD： a qualitative study[J].journal interventional radiology,2018,27(01):178.
[5]许凯豪,刘一铭,焦德超,等.新型部分覆膜式分支一体化T/Y型支架治疗肝门部胆管恶性梗阻[J].介入放射学杂志,2023,32(04):359.
　XU Kaihao,LIU Yiming,JIAO Dechao,et al.A new-type partially covered branch integration T/Y- shaped stent for malignant hepatic hilar biliary obstruction[J].journal interventional radiology,2023,32(01):359.

PDF下载中关闭

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

文章信息/Info

参考文献/References:

相似文献/References:

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics